{{Drugbox
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X4W3ENH1CV
| verifiedrevid = 595681188
| drug_name = Norepinephrine
| image = Norepinephrine.svg
| width = 180
| image2 = Norepinephrine ball-and-stick model.png
| width2 = 
| IUPAC_name = 4-[(1''R'')-2-amino-1-hydroxyethyl]benzene-1,2-diol
| synonyms = Noradrenaline<br />(''R'')-(–)-Norepinephrine<br />l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
<!--Identifiers-->
| IUPHAR_ligand = 505
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00368
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 18357
| smiles = Oc1ccc(cc1O)[C@@H](O)CN
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SFLSHLFXELFNJZ-QMMMGPOBSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 51-41-2
| PubChem = 439260
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1437
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 388394
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00076
| ATC_prefix = C01
| ATC_suffix =  CA03
<!--Clinical data-->
| tradename = Levarterenol, Levophed, Norepin, other
| Drugs.com = {{drugs.com|monograph|norepinephrine-bitartrate}}
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| licence_US = Norepinephrine
| legal_status = 
| dependency_liability = 
| routes_of_administration= 注射
<!--Physiological data-->
| source_tissues = [[蓝斑核|蓝斑核]]、[[交感神经|交感神经]]、{{link-en||adrenal medulla|adrenal medulla}}
| target_tissues = 全身性
| receptors = {{link-en||Alpha-1 adrenergic receptor|α<sub>1</sub>}}, {{link-en||Alpha-2 adrenergic receptor|α<sub>2</sub>}}, {{link-en||Beta-1 adrenergic receptor|β<sub>1</sub>}}, {{link-en||Beta-3 adrenergic receptor|β<sub>3</sub>}}
| agonists = [[拟交感神经药|拟交感神经药]]、[[可乐定|可乐定]]、{{link-en|异丙肾上腺素|isoprenaline}}
| antagonists = [[三环类抗抑郁药|三环类抗抑郁药]]、[[Β受体阻滞剂|β受体阻滞剂]]、[[抗精神病药|抗精神病药]]
| precursor =
| biosynthesis =
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism = {{link-en|單胺氧化酶A|Monoamine oxidase A|MAO-A}}；[[儿茶酚-O-甲基转移酶|儿茶酚-O-甲基转移酶]]
| elimination_half-life = 
| excretion = 尿（84–96%）
<!--Chemical data-->
| C=8 | H=11 | N=1 | O=3
| molecular_weight = 169.18 g/mol
| melting_point = 217
| melting_notes =（分解）
| density = 1.397±0.06
| boiling_point = 442.6
| boiling_notes = ±40.0°C
}}
<!-- 定義與醫療用途 -->
'''去甲基腎上腺素'''（英文名：Norepinephrine或Noradrenaline）為一種治療嚴重[[低血壓|低血壓]]的[[藥品|藥物]]<ref name=AHFS2017/>，通常於[[敗血症|敗血症]]患者[[靜脈注射|靜脈注射]]升壓藥物後，仍無法改善其低血壓時使用<ref>{{cite book|last1=Latifi|first1=Rifat|title=Surgical Decision Making: Beyond the Evidence Based Surgery|date=2016|publisher=Springer|isbn=9783319298245|page=67|url=https://books.google.ca/books?id=2Z8YDAAAQBAJ&pg=PA67|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170327165820/https://books.google.ca/books?id=2Z8YDAAAQBAJ&pg=PA67|archivedate=2017-03-27|df=}}</ref>。去甲腎上腺素的分子結構跟[[荷爾蒙|激素]]及[[神經傳遞物|神經傳導物質]]的[[去甲基腎上腺素|去甲基腎上腺素]]相同<ref name=AHFS2017/>，給藥方式為慢速[[靜脈注射|靜脈注射]]<ref name=AHFS2017>{{cite web|title=Norepinephrine Bitartrate|url=https://www.drugs.com/monograph/norepinephrine-bitartrate.html|publisher=The American Society of Health-System Pharmacists|accessdate=26 March 2017|deadurl=no|archiveurl=https://web.archive.org/web/20170326230032/https://www.drugs.com/monograph/norepinephrine-bitartrate.html|archivedate=26 March 2017|df=}}</ref>。

<!-- 副作用與機制 -->
常見的副作用有頭痛，心搏率減慢及[[焦慮|焦慮]]<ref name=AHFS2017/>，也可能會有[[心律不整|心律不整]]的副作用<ref name=AHFS2017/>。如果去甲腎上腺素從靜脈給藥處外漏，可能導致{{link-en|肢體缺血|limb ischemia}}<ref name=AHFS2017/>，若藥品外溢，可在受影響處局部給予抑腎上腺藥{{link-en|苄胺唑啉|Phentolamin}} （或稱芬妥胺），會比較有幫助<ref name=AHFS2017/>，去甲基腎上腺素作用方式有賴 α[[腎上腺素受體|腎上腺素受體]]結合及活化來進行<ref name=AHFS2017/>。

<!-- 歷史及文化 -->
此藥是在1946年研發成功，美國並於1950年核准使用在醫療用途<ref name=AHFS2017/><ref>{{cite book|title=Encyclopedia of the Neurological Sciences|date=2014|publisher=Academic Press|isbn=9780123851581|page=224|url=https://books.google.ca/books?id=hfjSVIWViRUC&pg=RA1-PA224|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20170327165724/https://books.google.ca/books?id=hfjSVIWViRUC&pg=RA1-PA224|archivedate=2017-03-27|df=}}</ref>，目前已有[[學名藥|學名藥]]上市<ref name=AHFS2017/>。2015年時，開發中國家取得此藥的批發價約為每瓶4毫克裝0.42美元<ref>{{cite web|title=Norepinephrine|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=558&searchYear=2015|website=mshpriceguide.org|accessdate=26 March 2017|deadurl=no|archiveurl=https://web.archive.org/web/20170326230310/http://mshpriceguide.org/en/single-drug-information/?DMFId=558&searchYear=2015|archivedate=26 March 2017|df=}}</ref>；在英國，國民保健署取得相同劑量的成本為4.4英磅<ref name=BNF69>{{cite book|title=British national formulary : BNF 69|date=2015|publisher=British Medical Association|isbn=9780857111562|page=145|edition=69}}</ref>。

==參考資料==
{{Reflist}}
{{Adrenergic_receptor_modulators}}

[[Category:强心剂|Category:强心剂]]
[[Category:变力剂|Category:变力剂]]
[[Category:重症医学|Category:重症医学]]